IL128144A - Ltb4 antagonistic benzamidine derivatives, process for their preparation and their use in the preparation of pharmaceutical compositions - Google Patents

Ltb4 antagonistic benzamidine derivatives, process for their preparation and their use in the preparation of pharmaceutical compositions

Info

Publication number
IL128144A
IL128144A IL12814497A IL12814497A IL128144A IL 128144 A IL128144 A IL 128144A IL 12814497 A IL12814497 A IL 12814497A IL 12814497 A IL12814497 A IL 12814497A IL 128144 A IL128144 A IL 128144A
Authority
IL
Israel
Prior art keywords
denotes
branched
unbranched
alkyl
reaction
Prior art date
Application number
IL12814497A
Other languages
English (en)
Other versions
IL128144A0 (en
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL128144A0 publication Critical patent/IL128144A0/xx
Publication of IL128144A publication Critical patent/IL128144A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
IL12814497A 1996-09-10 1997-09-09 Ltb4 antagonistic benzamidine derivatives, process for their preparation and their use in the preparation of pharmaceutical compositions IL128144A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19636689A DE19636689A1 (de) 1996-09-10 1996-09-10 Neue Benzamidinderivate
PCT/EP1997/004921 WO1998011062A1 (de) 1996-09-10 1997-09-09 Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung

Publications (2)

Publication Number Publication Date
IL128144A0 IL128144A0 (en) 1999-11-30
IL128144A true IL128144A (en) 2004-07-25

Family

ID=7805125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12814497A IL128144A (en) 1996-09-10 1997-09-09 Ltb4 antagonistic benzamidine derivatives, process for their preparation and their use in the preparation of pharmaceutical compositions

Country Status (30)

Country Link
US (2) US6197824B1 (tr)
EP (2) EP1203764B1 (tr)
JP (2) JP4150427B2 (tr)
KR (1) KR20000036005A (tr)
CN (1) CN1104412C (tr)
AR (1) AR009741A1 (tr)
AT (2) ATE224363T1 (tr)
AU (1) AU727900B2 (tr)
BG (1) BG63938B1 (tr)
BR (1) BR9712816A (tr)
CA (1) CA2262566C (tr)
CO (1) CO4900032A1 (tr)
CZ (1) CZ297252B6 (tr)
DE (3) DE19636689A1 (tr)
DK (1) DK0929516T3 (tr)
EA (1) EA003245B1 (tr)
EE (1) EE04431B1 (tr)
ES (1) ES2184131T3 (tr)
HU (1) HUP9904367A3 (tr)
IL (1) IL128144A (tr)
NO (1) NO312239B1 (tr)
NZ (1) NZ334895A (tr)
PL (1) PL188012B1 (tr)
PT (1) PT929516E (tr)
SK (1) SK282432B6 (tr)
TR (1) TR199900501T2 (tr)
TW (1) TW378200B (tr)
UA (1) UA60315C2 (tr)
WO (1) WO1998011062A1 (tr)
ZA (1) ZA978045B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE268751T1 (de) * 1997-11-20 2004-06-15 Teijin Ltd Biphenylamidin-derivate
CN1245381C (zh) * 1998-12-14 2006-03-15 弗·哈夫曼-拉罗切有限公司 苯基甘氨酸衍生物
DE19948428A1 (de) * 1999-10-07 2001-04-12 Boehringer Ingelheim Pharma Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
DE10052333A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
US6489359B2 (en) 2000-10-24 2002-12-03 Boehringer Ingelheim Pharma Kg Sulphoxybenzamides
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
US6608054B2 (en) * 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
WO2003007922A2 (de) * 2001-07-14 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelformulierung enthaltend einen ltb4 antagonisten
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
US20040006092A1 (en) * 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
DE10213350A1 (de) * 2002-03-26 2003-10-16 Boehringer Ingelheim Pharma Verwendung von LTB¶4¶Antagonisten in der Tiermedizin
US6921752B2 (en) * 2002-03-26 2005-07-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of LTB4 antagonists in veterinary medicine
RS20050390A (sr) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Farmaceutska kompozicija koja obuhvata ltb4 antagonist i koks-2 inhibitor ili kombinovani koks1/2 inhibitor
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
JP4657297B2 (ja) * 2004-07-05 2011-03-23 ドン ファ ファーマシューティカル カンパニー リミテッド アレルギー性炎症疾患の予防及び治療用組成物
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
US8679288B2 (en) * 2008-06-09 2014-03-25 Lam Research Corporation Showerhead electrode assemblies for plasma processing apparatuses
CN106831611B (zh) * 2017-01-23 2019-06-21 北京化工大学 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用
EP3623368A4 (en) 2017-05-12 2021-04-07 Riken MODIFIER OF A COMPOUND WITH CLASS A GPCR BOND
CN113164567A (zh) * 2018-09-24 2021-07-23 不列颠哥伦比亚大学 在治疗皮肤状况中调节颗粒酶k活性
GB202211232D0 (en) 2022-08-02 2022-09-14 Heptares Therapeutics Ltd Prostaglandin EP4 receptor agonist compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0518818A3 (en) 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5246965A (en) 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
PL173781B1 (pl) * 1992-02-05 1998-04-30 Boehringer Ingelheim Kg Sposób wytwarzania nowych pochodnych amidyny
DE4219158A1 (de) * 1992-06-11 1993-12-16 Thomae Gmbh Dr K Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
BR9712816A (pt) 1999-11-23
CA2262566C (en) 2006-07-11
SK29699A3 (en) 2000-03-13
KR20000036005A (ko) 2000-06-26
EP0929516A1 (de) 1999-07-21
US6265612B1 (en) 2001-07-24
EE04431B1 (et) 2005-02-15
ZA978045B (en) 1998-03-10
CZ297252B6 (cs) 2006-10-11
JP2001504087A (ja) 2001-03-27
DE59708278D1 (de) 2002-10-24
WO1998011062A1 (de) 1998-03-19
EA003245B1 (ru) 2003-02-27
CN1230174A (zh) 1999-09-29
US6197824B1 (en) 2001-03-06
JP2008266333A (ja) 2008-11-06
TW378200B (en) 2000-01-01
SK282432B6 (sk) 2002-02-05
NZ334895A (en) 2000-09-29
NO991131D0 (no) 1999-03-09
TR199900501T2 (tr) 1999-07-21
BG103219A (bg) 1999-10-29
IL128144A0 (en) 1999-11-30
PT929516E (pt) 2003-01-31
DK0929516T3 (da) 2003-01-13
ATE224363T1 (de) 2002-10-15
EP1203764A1 (de) 2002-05-08
PL332136A1 (en) 1999-08-30
HK1020564A1 (en) 2000-05-12
EP0929516B1 (de) 2002-09-18
DE19636689A1 (de) 1998-03-12
JP4150427B2 (ja) 2008-09-17
ATE266630T1 (de) 2004-05-15
NO991131L (no) 1999-03-09
AU727900B2 (en) 2001-01-04
JP4288299B2 (ja) 2009-07-01
AR009741A1 (es) 2000-05-03
CO4900032A1 (es) 2000-03-27
DE59711625D1 (de) 2004-06-17
HUP9904367A3 (en) 2001-11-28
CA2262566A1 (en) 1998-03-19
UA60315C2 (uk) 2003-10-15
AU4383897A (en) 1998-04-02
ES2184131T3 (es) 2003-04-01
HUP9904367A2 (hu) 2000-05-28
BG63938B1 (bg) 2003-07-31
CZ82299A3 (cs) 1999-09-15
EP1203764B1 (de) 2004-05-12
CN1104412C (zh) 2003-04-02
NO312239B1 (no) 2002-04-15
EA199900279A1 (ru) 1999-08-26
PL188012B1 (pl) 2004-11-30
EE9900086A (et) 1999-10-15

Similar Documents

Publication Publication Date Title
CA2262566C (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
US20030130232A1 (en) Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
HUT60462A (en) Process for producing biphenyl derivatives and pharmaceutical compositions comprising same
US5731332A (en) Substituted benzamidine compounds which have useful pharmaceutical activity
SK277762B6 (en) Carboxylic acid amides and sulfonic acid amides, method of their production and their using
CA2148930A1 (en) Substituted amidino compounds, their manufacture and methods of treatment
US5686496A (en) Chemical compound, the preparation thereof and its use in pharmaceutical compositions
JP3213327B2 (ja) ベンゾチアゾロン誘導体
JP2005530809A (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
CA1125312A (en) Alkylthiophenoxyalkylamines
CA2425368C (en) New sulphoxybenzamides
US6291531B1 (en) LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
US6288277B1 (en) Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
JPH09227495A (ja) フェノール誘導体及びその製法
EP0197386B1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
US6919328B1 (en) Tricyclic compounds with NOS activity
US6489359B2 (en) Sulphoxybenzamides
NZ207272A (en) Benzamide derivatives and pharmaceutical compositions
CA2385871C (en) Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
MXPA99001797A (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
HK1020564B (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
WO1997000239A1 (fr) Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
HK1008781B (en) Benzothiazolone derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees